Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8324157 | NOVO | Preparation comprising insulin, nicotinamide and an amino acid |
Jun, 2030
(6 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Patient Population(NPP) | Dec 19, 2022 |
New Product(NP) | Sep 29, 2020 |
M(M-247) | Oct 21, 2022 |
Market Authorisation Date: 29 September, 2017
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS, SUBCUTANEOUS
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8672898 | NOVO | Automatic injection device with reset feature |
Jan, 2022
(2 years ago) | |
US9486588 | NOVO | Automatic injection device with reset feature |
Jan, 2022
(2 years ago) | |
US6899699 | NOVO | Automatic injection device with reset feature |
Jan, 2022
(2 years ago) | |
US8579869 | NOVO | Needle mounting system and a method for mounting a needle assembly |
Jun, 2023
(10 months ago) | |
US7762994 | NOVO | Needle mounting system and a method for mounting a needle assembly |
May, 2024
(20 days from now) | |
US8684969 | NOVO | Injection device with torsion spring and rotatable display |
Oct, 2025
(1 year, 5 months from now) | |
US9457154 | NOVO | Injection device with an end of dose feedback mechanism |
Jan, 2026
(1 year, 8 months from now) | |
US10376652 | NOVO | Automatic injection device with a top release mechanism |
Jan, 2026
(1 year, 8 months from now) | |
US9616180 | NOVO | Automatic injection device with a top release mechanism |
Jan, 2026
(1 year, 8 months from now) | |
US9108002 | NOVO | Automatic injection device with a top release mechanism |
Jan, 2026
(1 year, 8 months from now) | |
US10357616 | NOVO | Injection device with an end of dose feedback mechanism |
Jan, 2026
(1 year, 8 months from now) | |
US9861757 | NOVO | Injection device with an end of dose feedback mechanism |
Jan, 2026
(1 year, 8 months from now) | |
US8920383 | NOVO | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
Jul, 2026
(2 years from now) | |
US10220155 | NOVO | Syringe device with a dose limiting mechanism and an additional safety mechanism |
Jul, 2026
(2 years from now) | |
US9775953 | NOVO | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
Jul, 2026
(2 years from now) | |
USRE46363 | NOVO | Dial-down mechanism for wind-up pen |
Aug, 2026
(2 years from now) | |
US7686786 | NOVO | Dial-down mechanism for wind-up pen |
Aug, 2026
(2 years from now) | |
US9687611 | NOVO | Injection device with torsion spring and rotatable display |
Feb, 2027
(2 years from now) | |
US8324157 | NOVO | Preparation comprising insulin, nicotinamide and an amino acid |
Jun, 2030
(6 years from now) | |
US9132239 | NOVO | Dial-down mechanism for wind-up pen |
Feb, 2032
(7 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Patient Population(NPP) | Dec 19, 2022 |
New Product(NP) | Sep 29, 2020 |
M(M-247) | Oct 21, 2022 |
Market Authorisation Date: 29 September, 2017
Treatment: NA
Dosage: SOLUTION;SUBCUTANEOUS